Cargando…
Immunotoxins and Anticancer Drug Conjugate Assemblies: The Role of the Linkage between Components
Immunotoxins and antibody-drug conjugates are protein-based drugs combining a target-specific binding domain with a cytotoxic domain. Such compounds are potentially therapeutic against diseases including cancer, and several clinical trials have shown encouraging results. Although the targeted elimin...
Autores principales: | Dosio, Franco, Brusa, Paola, Cattel, Luigi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3202854/ https://www.ncbi.nlm.nih.gov/pubmed/22069744 http://dx.doi.org/10.3390/toxins3070848 |
Ejemplares similares
-
Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potential
por: Immordino, Maria Laura, et al.
Publicado: (2006) -
Drug Conjugates Such as Antibody Drug Conjugates (ADCs), Immunotoxins and Immunoliposomes Challenge Daily Clinical Practice
por: Janthur, Wolf-Dieter, et al.
Publicado: (2012) -
Hyaluronic Acid Conjugates as Vectors for the Active Targeting of Drugs, Genes and Nanocomposites in Cancer Treatment
por: Arpicco, Silvia, et al.
Publicado: (2014) -
Immunotoxins: The Role of the Toxin (†)
por: Antignani, Antonella, et al.
Publicado: (2013) -
Targeted Anticancer Immunotoxins and Cytotoxic Agents with Direct Killing Moieties
por: Kawakami, Koji, et al.
Publicado: (2006)